Earnings season ramps up another notch next week to start February, forcing investors to wade through a barrage of quarterly results amid ongoing policy uncertainty that promises upheaval for an already choppy stock market. The January jobs report is also due out Friday. Next week will be the busiest stretch … Read more
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in Washington, U.S., November 20, 2020. Carlos Barria | Reuters Pharmaceutical companies appear to be hopeful about their growth under a Trump administration, after former President Joe Biden … Read more
Nothing like going to one of the largest research conferences in the world and having everyone down in the dumps about their sector. That was the case from the moment I got to JPMorgan’s annual health healthcare conference in San Francisco on Monday to the moment I wrapped up my … Read more
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey | Reuters The Biden administration on Friday unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off the second phase of … Read more
Trends may be shifting in favor of biotech stocks in 2025 after several years of poor performance, but it would still be wise to place your bets carefully on some of the most innovative names. “We’re still optimistic on the outlook for biotech,” said Stacey Sears, senior vice president and … Read more
You can’t ban froth. You can’t ban lunacy, especially when it pays off. You can’t tell the insiders or big data analytics specialist Palantir to take profits. You can’t stop the executives at Applovin from bailing up here, and you can’t tell the buyers of that mobile gaming ad software … Read more
President-elect Donald Trump at a viewing of a test-flight launch of the SpaceX Starship rocket in Brownsville, Texas, Nov. 19, 2024. Brandon Bell | Getty Images News | Getty Images As Inauguration Day nears, investors are trying to unravel what booms or busts lay ahead under President-elect Donald Trump. Trump’s … Read more
The U.S. presidential election beckons and even though nearly 75 million people have already voted, according to NBC News , nothing seems to have leaked out. You would figure the hedge fund algorithms would have picked up something by now, but I haven’t seen any confirmed bets made either way. … Read more
Eli Lilly shares fell Wednesday after the diabetes-and-obesity drug giant posted disappointing third-quarter results and lowered its full-year sales guidance. The report was messy, but it doesn’t dim Eli Lilly’s bright multiyear outlook, rendering the dip in the stock as a chance to buy. Revenue in the three months ended … Read more
Every Friday I do a gameplan look-ahead on “Mad Money.” It has to be cursory because I write about 1,200 words — which has to fit into one segment on television — that’s the typical structure/stricture. I can’t really dally on any particular earnings report because that means I won’t … Read more
